User menu

A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke

Bibliographic reference Teal, Philip ; Davis, Stephen ; Hacke, Werner ; Kaste, Markku ; Lyden, Patrick D ; et. al. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke. In: Stroke : a journal of cerebral circulation, Vol. 40, no. 11, p. 3518-3525 (2009)
Permanent URL http://hdl.handle.net/2078.1/123821